Search results “John hoppkins prostate cancer”
John’s Hopkins AR-V7 Test in Prostate
Emmanuel S. Antonarakis, MBBCh, shares his views on the Johns Hopkins AR-V7 test in development for prostate cancer.
Views: 201 OncLiveTV
Current Issues in Prostate Cancer: Johns Hopkins Medicine
Prostate cancer detection and treatment remains an area of controversy. Expert guidance to help you negotiate whether or not to be tested and which management and treatment strategies are appropriate can be found at Johns Hopkins, as can the latest in research. For more information go to http://urology.jhu.edu/
Active surveillance for Prostate Cancer (AUA 2015)
At the AUA annual meeting in New Orleans a panel of experts from John Hopkins University, UCLA and New York University and moderator Dr. Stacey Loeb, Urologist & prostate cancer researcher at New York University discussed the effectiveness, trends and other considerations for active surveillance in managing prostate cancer
Views: 728 Urology Times
Robotic Prostate Surgery | Q&A
Robotic Surgery Director, Dr. Mohamad Allaf, discusses Johns Hopkins' prostatectomy program, including the Brady Urological Institute's robust robotic experience, prostatectomy pioneer Dr. Walsh, and unique post-operative care provided at Hopkins. For more information please visit: http://www.hopkinsmedicine.org/urology Questions Answered: 1. What is prostate cancer and how does it develop? 0:03 2. How is prostate cancer diagnosed? 0:34 3. What is the difference between a robotic prostatectomy and an open prostatectomy? 2:18 4. Why should patient come to Johns Hopkins for treatment of prostate cancer? 2:53 5. Who is included in the care team? 4:05 6. What is recovery like after prostatectomy? 5:07 7. Are there any specific recommendations for patients with prostate cancer? 5:51
The Ketogenic Diet and Cancer
Dr. Mike explains how a ketogenic diet can prevent and even cure cancer by depriving cancer cells of glucose, which is their only energy source. For more True Health content, Subscribe to Dr. Mike's channel for more awesome videos at https://www.youtube.com/drmichaelvandc Get his new book here: https://www.amazon.com/Scientific-Approach-Intermittent-Fasting/dp/1536977411/ref=cm_cr_arp_d_product_top?ie=UTF8 Follow me on Facebook: http://www.facebook.com/dr.michaelvan Instagram: DrMichaelVan Twitter: @DrMikeVan References: 1. Lee C, Raffaghello L, Brandhorst S, et al. Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy. Science Translational Medicine. 2012;4(124):124. 2. Brandhorst S et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metabolism. 2015;22(1):86-99. 3. Rocha NS, Barbisan LF, de Oliveira ML, de Camargo JL. Effects of fasting and intermittent fasting on rat hepatocarcinogenesis induced by diethylnitrosamine. Teratog Carcinog Mutagen. 2002;22(2):129-38. 4. Descamps O, Riondel J, Ducros V, Roussel AM. Mitochondrial production of reactive oxygen species and incidence of age-associated lymphoma in OF1 mice: effect of alternate-day fasting. Mech Ageing Dev. 2005 Nov;126(11):1185-91. 5. New York Times May 12, 2016 6.http://articles.mercola.com/sites/articles/archive/2016/05/30/how-high-fat-diet-helps-starve-cancer.aspx?utm_source=dnl&utm_medium=email&utm_content=art1&utm_campaign=20160530Z1&et_cid=DM107077&et_rid=1506330338 7. Koppenol WH, Bounds PL, Dang CV. Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011 May;11(5):325-37. At http://bergmanchiropractic.com and http://Owners-Guide.com we strive to educate people on natural solutions to health. http://www.theArthritisReversalSystem.com is my online video course with 21 videos, 3 manuals and an online forum! https://www.owners-guide.com/online-consultation/ for online consults. SUBSCRIBE at http://www.youtube.com/user/johnbchiro CALL TOLL FREE 1-855-712-0012 to get bonus materials not on YouTube or text your first name and email plus 89869 to 1-817-591-2905.
Views: 595747 Dr. John Bergman
Hopkins - Episode 4
Peyton Penrod is a healthy toddler who suddenly needs to be rushed to the Hopkins PICU, one of the country's top ICUs for children.
The Whipple Procedure | Johns Hopkins Medicine
The type of operation performed for removal of pancreatic cancer is based on the location of the tumor. For tumors of the head and neck of the pancreas a Whipple procedure, (also called a pancreaticoduodenectomy) is performed. This is a complex operation perfected at Johns Hopkins. This video will explain the surgery and what patients can expect. Learn more about the Whipple procedure at Johns Hopkins: http://www.hopkinsmedicine.org/pancreatic_cancer_center
Views: 524751 Johns Hopkins Medicine
Robotic Prostate Surgery | Q&A
Robotic Surgery Director Dr. Mohamad Allaf discusses Johns Hopkins' prostatectomy program, including the Brady Urological Institute's robust robotic experience, prostatectomy pioneer Dr. Walsh, and unique post-operative care provided at Hopkins. For more information: http://www.hopkinsmedicine.org/urology Questions answered: 1. Describe what you do. (0:11) 2. How many prostatectomies are performed each year at Johns Hopkins? (0:24) 3. How many robotic prostatectomies are performed each year at Johns Hopkins? (1:01) 4. Why does volume matter -- don't most hospitals perform these same procedures? (1:40) 5. Now that Dr. Patrick Walsh has retired, how has his work influenced the new generation of urologists? (2:15) 6. How important is the nursing and post-operative care in the recovery of patients with prostate cancer? (2:55) 7. How is the Hopkins approach to prostate surgery unique? (3:35) 8. What else makes our program unique? (4:20)
Views: 22877 Johns Hopkins Medicine
Current Mortality Rates on Prostate Cancer Patients
John W. Davis, MD, FACS, provides an overview of current mortality rates in prostate cancer patients and multiple factors, including methods of prostatectomy, inherent risks, and adverse events to treatments. He also gives his opinions on how the United States Preventive Services Task Force (USPSTF) PSA testing recommendations have affected this data.
"The Substance" - Interview with Johns Hopkins Psilocybin Cancer Project Participant 1
This interview is footage from a documentary called "The Substance". The volunteer was a participant in the Johns Hopkins Psilocybin Cancer Project supported by the Heffter Research Institute: www.heffter.org. For more information on the documentary, check out: www.thesubstance-themovie.com If you want permission to use, please seek approval from Andres at venturaATventurafilmDOTch
Recent AR-V7 Data in Prostate Cancer
Emmanuel S. Antonarakis, MBBCh, and Howard I. Scher, MD, outline the recent AR-V7 data presented at the ASCO 2017 meeting for prostate cancer.
Views: 335 OncLiveTV
This New Treatment Will Terminate Cancer: Johns Hopkins Medical Update
Current cancer treatments try to eliminate cancer cells... but what if we just immobilized them for easy extraction, Terminator-style? Research from Dr Douglas Robinson and Alexandra Surcel could revolutionize the way cancers is treated. ScIQ spoke to the duo back in January 2015 about their exciting work - a big thank you to Doug and Alexandra for your continued support and patience whilst we launched this special feature! From Johns Hopkins Medical: Existing cancer therapies are geared toward massacring tumor cells, but Johns Hopkins researchers propose a different strategy: subtly hardening cancer cells to prevent them from invading new areas of the body. They devised a way of screening compounds for the desired effect and have identified a compound that shows promise in fighting pancreatic cancer. Their study appears this week in the early edition of the Proceedings of the National Academy of Sciences. “This is a novel approach to cancer therapy that we believe could fight the disease with less potential for side effects and drug resistance than many current drugs,” says Douglas Robinson, Ph.D., a professor of cell biology in the Institute for Basic Biomedical Sciences at Johns Hopkins University School of Medicine. “We think the new screening system we devised will help identify drugs for many other diseases, as well.” The roots of the project go back to 1997, when Robinson, then a postdoctoral fellow, says he first had the idea that better understanding how a cell divides into two would shed light on how cells change shape in general. Since changes in cell shape figure into conditions from cancer to chronic obstructive pulmonary disease to degenerative nerve diseases, compounds that affect cells shape could turn out to stall disease progress. For more information: http://www.hopkinsmedicine.org/news/media/releases/new_cancer_fighting_strategy_would_harden_cells_to_prevent_metastasis This video is presented by Jayde Lovell, produced and edited by Bec Susan Gill and Yohana Yoshe NYC. SCIQ ON TYT Produced by Jayde Lovell and Bec Susan Gill. ScIQ is a partner of the TYT Network. Follow SciQ on Twitter: http://www.twitter.com/ScIQ_TYT Follow SciQ on Facebook: https://www.facebook.com/sciq.tyt?ref=hl Follow SciQ on Tumblr: http://dssscience.tumblr.com/ Follow Jayde on Twitter: https://twitter.com/jaydelovell Follow Jayde on Instagram: www.instagram.com/jaydelovell Follow Jayde on the interwebs: www.jaydelovell.com Follow Bec on Twitter: https://twitter.com/becsusangill Follow Bec on Instagram: https://instagram.com/becsusangill Follow Bec on Tumblr: http://becsusangill.tumblr.com/ CONTACT For enquiries – please email bec@tytnetwork.com or jayde@tytnetwork.com
Views: 1525 ScIQ
Dr. Lepor Discusses Open Prostatectomy in Treating Prostate Cancer
Dr. Herbert Lepor is an internationally recognized authority in the treatment of prostate cancer. In collaboration with Patrick Walsh, his mentor as Johns Hopkins Brady Urological Institute, Dr. Lepor pioneered the development of the nerve sparing radical prostatectomy. He has performed more than 4000 open procedures on men from all corners of the world with superior published results. Visit us at: SmilowProstateCancerCenter.org http://prostate-cancer.med.nyu.edu/
Views: 905 SmilowCenter
Prostate Cancer: Discovery and Importance of AR-V7
Emmanuel S. Antonarakis, MBBCh, and Andrew J. Armstrong, MSc, discuss how AR-V7 was discovered and its clinical importance in treatment decisions in metastatic castration-resistant prostate cancer.
Views: 416 OncLiveTV
Prostate Cancer Recovery- Dr.Bivalacqua
Prostate Cancer Recovery
Views: 1263 Johns Hopkins Urology
Arthur L. Burnett, II, M.D., MBA, presents -Sexual Dysfunction after Prostate Cancer
"Sexual Dysfunction after Prostate Cancer " Arthur L. Burnett, II, M.D., MBA Patrick C. Walsh Distinguished Professor of Urology Director, Sexual Medicine Fellowship Program John Hopkins University School of Medicine in Baltimore, MD, presents "Addressing Sexual Dysfunction after Prostate Cancer" at PHEN Tenth Annual African American Disparity Summit which took place September 25th - 26th, 2014, at the Russell Senate Building in Washington DC.
Rural Medicine Grand Rounds 2015 - Prostate Cancer
Moderator: Dr Lucy Ingram Presenter: Dr Edan Buxton Panellists: • Dr John Hall, Rural GP, Oakey • Julie Westaway, Clinical Nurse Consultant Urogynaecology and HACC Continence Advisory Service • Dr Jacob Gleeson, Urologist, St Andrews Hospital Toowoomba A panel of experts discuss issues surrounding the diagnosis and management of patients with Prostate Cancer in a rural area. To protect confidentiality, cases have been de-identified and features of patient stories have been altered
Believing and Belonging | Peter Pronovost | TEDxBeaconStreetSalon
On a snowy night in 2002 an 18 month-old girl died from a preventable infection that kills 30,000 people each year, as many as die of breast or prostate cancer. Rejecting the conventional wisdom of the era, Dr. Peter Pronovost and researchers at John's Hopkins set out to transform a foundational idea of medical practice. In reducing that infection rate by 80%, Dr. Pronovost and his colleagues discovered the "secret sauce" for achieving profound change in otherwise inflexible professional cultures. He shares the secret here for applying it to situations beyond medicine. Peter Pronovost is a world-renowned patient safety champion and a practicing critical care physician. His scientific work leveraging checklists to reduce catheter-related bloodstream infections has saved thousands of lives and earned him high-profile accolades, including being named one of the 100 most influential people in the world by Time Magazine and receiving a coveted MacArthur Foundation “genius grant” in 2008. Elected to the Institute of Medicine in 2011, Dr. Pronovost is an advisor to the World Health Organizations’ World Alliance for Patient Safety and regularly addresses the U.S. Congress on patient safety issues. He is Senior Vice President of Patient Safety and Quality, and the Director of the Armstrong Institute for Patient Safety and Quality at Johns Hopkins Medicine. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at http://ted.com/tedx
Views: 4920 TEDx Talks
Michael Milken - "Changing the Face of Prostate Cancer"
Michael Milken is the Founder and Chairman of The Prostate Cancer Foundation, the largest Prostate Cancer research Foundation in the World and they're committed to curing Prostate Cancer. Follow our blog at http://LifeInsuranceProstateCancer.com To discuss your specific Life Insurance needs for men with prostate cancer or request a life insurance quote if you have cancer such as prostate cancer, call us at - 844-LIFE-844 Make sure to follow us at - Google+ - https://google.com/+Lifeinsuranceprostatecancer Facebook - https://facebook.com/LifeInsuranceProstateCancer Twitter - https://twitter.com/LifeInsureCaP This video is the property of The Bridgespan Group TRANSCRIPT When they tell you have 12 to 18 months to live. It's definitely a wake up call. For me in '93 I have lost 10 of my relatives to cancer and my prognosis was worse than any of them. So, I had to figure out what was I going to do different? What could I do? I've been funding cancer research for 20 years and knew nothing about prostate cancer. So the goal was you have to change a paradigm. By visiting cancer centers the first thing that I discovered was that it was considered suicide to work in the field of prostate cancer. So the first commitment was we committed $25 Million. Jonathan Simons who today in 2012 is the CEO of The Prostate Cancer Foundation, was that young scientist I met back at Hopkins in 1993. Brilliant, young, physician scientist whom they told, if he wants to go work in prostate cancer research that's career suicide. Luckily I met him with Bill Nelson who today runs the cancer center at John Hopkins and told them they picked the right field. Not only was it not career suicide but it's going to be the best funded research that he's ever seen. So first, you've got to jump start it. Second, I was visiting MD Anderson and I noticed there was no one from Memorial Sloan Kettering at MD Anderson. One of the scientist told me they're a competitor.They're a competitor for patients. I told them there are no competitors. As a patient or philanthropist we want teamwork. There is not a competition here. And so we launched these fast track awards. I went over to the National Institute of Health and the National Cancer Institute and I saw a submission of nine feet for an award. They had been working on it 18 months. They would find out whether they got approval or not in 18 months. Whatever it was 3 years later it wasn't even relevant anymore at the speed science was moving. So we decided we're going to announce a program that you can submit nine feet, but we only promise to read the first 5 pages. In addition to that, we will let you know whether you're going to be funded in 6 months and we will fund you within 90 days. So the waiting period was over. Third. Most scientist were spending half their time or two-thirds of their time trying to raise money. Therefore, we'll go help raise money for you. We can increase your productivity by 100% or by 300% by letting us take responsibility or raising money for your programs and you taking responsibility for focusing full-time on your program. Now many people said you know our work is so important that we can't share. Were going to have an article in Nature coming out in 12 months and I understand your work is so important. Our funding is only for those that work is not as important as yours. Ok. The people we fund have to share. They have to share with others. We can't wait 12 months. And so, because your work is so important you'll have no trouble getting whatever funding you'll need for your program; we're going to give our money to those that share. Within 6 months, every single person that told us they could not share, shared! Fourth. Go public. I looked at a program in Hopkins, they spent 12 years identifying families with more than 2 people in a family had had prostate cancer. Going to individuals, doctors and scientist looking for referrals. In 1995 we decided to put on a cancer summit. And we went on CNN. I called Larry King and said Larry, we want to do a show on cancer. He said, Mike, are you crazy? People get depressed by a show about cancer. I told Larry, Larry do you know 1 in 2 men and 1 in 3 women get cancer? He says this is ratings sweeps I need high ratings. I said okay, Larry, I'm going to call Ted. I called Ted and said, Ted this show will be successful. So low and behold they agreed to do a show. Three thousand people where more than 2 people in a family had prostate cancer watched and called in within the next 30 days. We accomplished more in collecting families in 30 days than had been achieved in 12 years. Today, crowdsourcing and other things can help you find those individuals. This created a movement to be part of a team. And, coupled with young investigators changed the face of prostate cancer not only in the United States but throughout the World.
Views: 147 LifeInsurancePro
Johns Hopkins researchers are studying how prostate cancer cells spread
The researchers at Johns Hopkins are studying how a specific protein plays a key role in why prostate cancer cells spread.
Views: 41 WMAR-2 News
20 for the 20th: Sidney Kimmel Comprehensive Cancer Center at John Hopkins University
William G. Nelson, M.D., Ph.D. is a member of our Scientific Advisory Board. Vasan Yegnasubramanian, M.D., Ph.D., is an Assistant Professor of Oncology at John Hopkins. Watch and learn about Dr. Yegnasubramanian's research. Help them "Pass the V': www.jimmyv.org/passthev.
The U. S. Preventive Service Task's current recommendation about the value of PSA testing has become controversial. In light of the controversy about the value of PSA testing, we are providing a video response from Dr. Charles "Snuffy" Myers, a nationally recognized medical oncologist and prostate cancer survivor. For more information on Dr. Myers video go to Ask Dr. Myers. (http://askdrmyers.wordpress.com/) For related articles on PSA testing: 1. John Hopkins Medicine " PSA screening is the best test available for the detection of cancer cells in the prostate. Rather than discontinuing use of the only test available to detect the disease early and treat it successfully, efforts should focus on reducing harm" For more info go to:http://www.johnshopkinshealthalerts.com/alerts/enlarged_prostate/PSA-guidelines_6020-1.html?ET=johnshopkins:e72972:87503a:&st=email&s=EEH_120103_001 2. M.D. Anderson "Men should not write off the PSA test," says John W. Davis, M.D., assistant professor in MD Anderson's Department of Urology. "It is still an effective way to track trends in your prostate over time." For more info go to http://www.mdanderson.org/publications/focused-on-health/issues/2010-september/psaresults.html
Views: 604 DadsDay5k
Prostate Cancer Treatment in India
http://www.medicaltourismco.com/india-hospitals/surgeon-videos/prostate-cancer-laser-surgery-india.php In this video, a famous urologist from India talks about his education and experience in prostate cancer laser treatment, in India. He is a master of Urology and a board certified transplant surgeon, both in the US and Canada. Being trained in Queen Elizabeth Health Sciences Centre in Halifax, he got an opportunity to work in the pediatric hospital, which is considered to be the second best pediatric hospital in North America, Toronto. Prostate cancer urologist has also done training in pancreas transplant at John's Hopkins and published about hundred papers in PR review publications about prostatectomy in India. The urologist talks about his main area of interest, which has always been laser urology. He states his experience in the use of both Holmium laser for stone disease of the kidney as well as use of laser for vaporization procedure of the prostate and cancer bladder. The other area of interest is reconstructive urology extending from buccal mucosa urethroplasty as well as androgenization and feminization techniques including penile prosthesis. Then the urologic oncologist talks about endoscopic techniques used for Pediatric reconstructive urologies and also talks about advantages of green light laser prostatectomy, as it provides excellent vision in presence of bleeding. All these factors make prostate cancer laser treatment in India, a safe and affordable option for international tourists. Please click on the link above for more information prostate cancer treatment in India.
Views: 1846 MedicalTourismCo
French hospital tests new prostate cancer treatment
A hospital in Lyon, France, is testing a new method for the treatment of prostate cancer involving a combination of MRI and 3D imaging, as an alternative to surgery or radiation therapy that presents far fewer complications. Duration: 00:54
Views: 1156 AFP news agency
Christian Pavlovich, M.D , Johns Hopkins Medicine, Department of Urology
Dr. Pavlovich came to Johns Hopkins after completing a Urologic Oncology fellowship at the National Cancer Institute. His practice is dedicated primarily to the treatment of prostate, kidney and bladder cancer, as well as to the treatment of benign prostatic diseases. He is experienced in open, laparoscopic, and robotic minimally invasive surgery for the management of urologic tumors, including nerve-sparing laparoscopic and robot- assisted radical prostatectomy, laparoscopic and robotic nephrectomy and partial nephrectomy, and robotic radical cystectomy. http://urology.jhu.edu/christianpavlovich/
Views: 3728 Johns Hopkins Urology
Atualizações sobre Cancer do Hospital John Hopkins   EUA
Tratamento e prevenção do câncer
Views: 212 Alzir Fraga
2000th Whipple at Johns Hopkins Medicine
Dr. John Cameron performed his 2000th Whipple surgery on March 30th, 2012. The Whipple procedure (also known as a pancreaticoduodenectomy) is a surgical treatment for pancreatic cancer and has been perfected for over 30 years at Hopkins - in large part due to Dr. Cameron.
Views: 13361 Johns Hopkins Medicine
Penile Rehabilitation after Cancer Treatments | Memorial Sloan Kettering
Learn more about our cancer treatments here: http://www.mskcc.org/morescience Like us on Facebook: http://www.facebook.com/sloankettering Follow us on Twitter: http://twitter.com/sloan_kettering Men who have had surgery or radiation treatment for prostate cancer can benefit greatly from penile rehabilitation — the use of PDE5 inhibitors, penile injections, and penile implants — to protect and maximize erectile function, says Memorial Sloan Kettering Cancer Center sexual health specialist, John Mulhall, MD. {partial transcript} Let’s talk about Penile Rehabilitation, also called erectile tissue preservation. Penile Rehabilitation is the use of any drug or device at or after radical prostatectomy or radiation therapy to maximize erectile function recovery. The purpose is to prevent erectile tissue damage – damage to the muscle and the endothelium in the penis. Our purpose is to protect it from atrophy and degeneration. Our goal is to get you back to where you were before your prostate cancer treatment. The strategies that are used, neuroregenerative drugs, PD5 inhibitors – the group of drugs that Viagra, Lavitra and Cialis belong to, and penile injections. There is very little evidence that transurethral prostaglandin or a vacuum device are a rehabilitation strategy at this point in time, although I think we’re going to have trials in the not to distant future. We are not going to spend a lot of time talking about neuroregenerative drugs; however it is a very hot topic in the field at the moment. Drugs developed specifically to prevent nerves from being damaged, whether it be surgery or radiation and increase the chances of other nerves regenerating.
Prostate Cancer: Advice for Oncologists on AR-V7 Testing
Emmanuel S. Antonarakis, MBBCh, and Howard I. Scher, MD, provide practical advice for oncologists regarding the future of AR-V7 testing in patients with prostate cancer.
Views: 490 OncLiveTV
Prostate Cancer Diagnosis: Patient Stories
When David Smith, Ian Graham Jones, and David Childs Hopkins had tests on their prostate, prostate cancer was the furthest thing from their mind. Find out what led these patients to see their doctor, how their prostate cancer was diagnosed, the tests they needed, and what their diagnosis meant to them, in the following short film. If you're concerned about your prostate then don't delay seeing your doctor. It could simply be an enlarged prostate, easily treated with medication and life style changes, but it could also be prostate cancer. The earlier prostate cancer is diagnosed the more effective the treatment. Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe. Find us at: http://www.streamingwell.com Subscribe to Streaming Well: http://www.youtube.com/subscription_center?add_user=StreamingWell Like us on: http://www.facebook.com/StreamingWell Follow us on: http://www.twitter.com/StreamingWell Follow us on: http://www.instagram.com/streamingwell Follow us on: http://pinterest.com/StreamingWell/
Views: 437 streamingwell
Radical Retropubic Prostatectomy: 2004
The Walsh Nerve-sparing Technique for Radical Retropubic Prostatectomy: A Detailed Description of the Surgical Technique, 2004
Views: 54890 Johns Hopkins Urology
Prostate Cancer Still Unlikely To Spread, But Aggressive Cancer Is On The Rise
Cases of aggressive prostate cancer appear to be on the rise, but the good news is it's still rare for prostate cancer to spread. Dr. Edward Schaeffer is chair of urology at Northwestern University Feinberg School of Medicine and Northwestern Medicine. According to NBC News, Schaeffer's team of researchers found that just 3 percent of cases have already started spreading when men are diagnosed. Better still, prostate cancer overall has not become more common. However, they found that cases of metastatic prostate cancer — the type that has started to spread in the body — nearly doubled in men aged 55 to 69 since 2004. The reason is not yet clear. Schaeffer is a strong advocate of prostate cancer screening and is critical of newer recommendations that men don't usually need regular screening. Prostate cancer is very common, showing up in 240,000 U.S. men every year. It kills about 30,000 a year. Once cancer has begun to spread in the body, it usually cannot be cured. http://www.nbcnews.com/health/mens-health/cases-aggressive-prostate-cancer-rise-research-finds-n612661 http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
Views: 117 Wochit News
The Johns Hopkins Kimmel Cancer Center Presents: Yoga Nidra
Yoga and meditation may promote many health benefits, such as reducing fatigue and stress, for cancer survivors, patients actively in treatment or receiving palliative care, and caregivers. Yoga nidra is a guided meditation to induce full-body relaxation and deep rest. It helps quiet the overactive mind and brings it into a conscious, meditative state. Yoga nidra has been found to reduce symptoms of anxiety, post-traumatic stress disorder, chronic pain and insomnia. Led by Claudia Simpson, yoga therapist. Learn more about cancer survivorship: www.hopkinsmedicine.org/kimmel_cancer_center/centers/cancer_survivorship/.
Views: 12980 Johns Hopkins Medicine
Prostate Cancer Surgery
Prostate Cancer Surgery Posterior Prostatic Dissection
Prostate Cancer Surgery
Developing the Space of Retzius
Dr. Loeb on the Results of Active Surveillance for Prostate Cancer
Stacy Loeb, MD, assistant professor of Urology and Population Health at New York University, discusses the results and impact of active surveillance on patients with prostate cancer.
Views: 268 OncLiveTV
AR-V7 as a Predictive Marker in Prostate Cancer
Andrew J. Armstrong, MSc, reviews how to use AR-V7 testing to drive treatment decisions and resistance mechanisms of abiraterone and enzalutamide in patients with prostate cancer.
Views: 867 OncLiveTV
Presidente Santos sera operado tras reaparición de cáncer de próstata
El presidente Juan Manuel Santos fue hospitalizado esta mañana de urgencia en la Fundación Santa Fé y viajará mañana a Baltimore, específicamente al hospital John Hopkins para ser intervenido quirugicamente al reaparecer el cáncer de próstata que lo aqueja hace varios años. Quieres ver más vídeos? Síguenos en nuestras redes: Youtube: http://videosdetodito.com Facebook: https://www.facebook.com/VideosDeTodito/ Twitter: https://twitter.com/VideosDT Blogger: http://videosdetoditoweb.blogspot.com.co/
Views: 408 Videos DeTodito
Prostate Cancer & Translational Medicine - Stephen B. Strum, MD
This is a preview of Prostate Cancer as a Prototype for Integrative Medicine: It is Time to Start Practicing Translational Medicine - Stephen B. Strum, MD at the 2008 A4M Las Vegas Conference. Visit www.instatapes.com to purchase this lecture and many others on DiGiVision, video and slides synced. Also, visit www.worldhealth.net for the conference sponsor. Item #A4M083D1-08
Views: 1752 DigiVision Media
Trinity Bivalacqua MD PhD | Urological Oncology
Dr. Bivalacqua has an active clinical practice in Urologic Oncology and Sexual Dysfunction. As a member of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Dr. Bivalacqua participates in multidisciplinary approaches to the treatment of a variety of genitourinary cancers. He has a special interest in cancers of the prostate and bladder with an emphasis on organ sparing therapies, minimally invasive techniques (nerve-sparing robotic assisted laparoscopic radical prostatectomy) and robotic-assisted laparoscopic radical cystectomy) and orthotopic bladder substitution (neobladder).
AACR 2010: Association between weight gain and prostate cancer risk
Corinne E. Joshu, postdoctoral fellow at the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health, speaks about the association between weight gain and an increased risk of prostate cancer recurrence in the PSA era. Speaking at the 2010 AACR conference.
Views: 75 ecancer
Mack Roach III, MD - "Treatment of Prostate Cancer in Developing Countries"
Dr. Mack Roach III of the University of California San Francisco presents his lecture "Treatment of Prostate Cancer in Developing Countries: the Use of 3D as Opposed to IMRT for Locally Advanced Prostate Cancer" at the Greater Horn Oncology Symposium (GHOS) on March 25, 2014. GHOS was a multidisciplinary oncology symposium designed to improve access to cancer care in the Greater Horn of Africa and as a forum for exchange of ideas between oncologists from around the world. The event was hosted by Kilimanjaro Christian Medical Center (KCMC) in Moshi, Tanzania on March 24 and 25, 2014. The event was organized by Radiating Hope, a US-based non-profit organization founded by radiation oncologists Brandon Fisher and Larry Daugherty, with the leadership of Dr Mira Shah, a radiation oncologist with the Henry Ford Hospital in Detroit, and support of Charlie Wittmack, a humanitarian-attorney and the President of Charity-Launch. During the symposium, lecturers discussed common local malignancies, early detection, and treatment. Specific topics included telemedicine, cervical cancer screening, sarcoma brachytherapy and breast brachytherapy, among other topics focusing on cancer care, prevention, early detection as well as treatment. The event also included industry panels, which were assembled to discuss the future of cancer treatment in the region as well as what physical facilities should be built to best serve Tanzania. To learn more about Radiating Hope, visit RadiatingHope.org. To learn more about Charity-Launch, visit Charity-Launch.com.
Views: 443 Charity-Launch
Views: 1842 Johns Hopkins Urology
Prostate Cancer Genetics - Autopsy Study 2
Pathologist G. Steven Bova discusses the utility of autopsy studies in gathering information on prostate cancer genetics. Recorded on March 31, 2009 using a Flip Video camcorder.
RACING to Raise Money for a NEW Prostate Cancer Cure!
Dr. Ashley Ross of the Prostate Cancer Research Center at Johns Hopkins explains how some of the promising new treatment technologies work. For more info on his work go to www.Urology.Jhu.Edu. John and Todd Wieslander of Kent Island Marine and the "Racing for a Cure" charity are raising awareness and money for Prostate Cancer Research through car racing. Learn more at www.KentIslandMarine.Com. Thanks for watching QACTV --- Please subscribe to get more Queen Anne's County Videos and be sure to visit our website http://qac.org/410/QACTV Follow us on Facebook at https://www.facebook.com/qactv7/ Follow us on Twitter at https://twitter.com/qacpressrelease Visit our website to see the latest Queen Anne's County Meetings at https://www.qactv.com And if you have cable, watch us on Atlantic Broadband Channel 7 Email us at qacpressreleases@gmail.com Please Note: Queen Anne’s County is not responsible for the content provided on “related” and “promoted” videos that are accessible from this county’s YouTube channel. All viewers should note that these related videos and comments expressed on them do not reflect the opinions and position of the Queen Anne’s County Government or its employees.
Views: 88 QACTV
The Only Metastatic Cancer Survivor Retreat of its Kind
At Johns Hopkins, we offer metastatic breast cancer survivors more than medicine http://www.hopkinsmedicine.org/breastcenter. When a cancer patient completes their treatment, they look forward to celebrating their survivorship but for those forced to deal with metastatic disease, such a celebration will not be in their future. The Johns Hopkins Breast Center holds retreats for stage IV breast cancer survivors and the result is a weekend experience that has been transformational for those who attend as a patient, caregiver, or medical provider. Funding for the Johns Hopkins Metastatic Breast Cancer Couples Retreat has been generously provided by The Salisbury Family Foundation.
USA - Brain Implant Attacks Cancer Tumours
(30 May 1994) BRAIN IMPLANT ATTACKS CANCER TUMOURS Washington, USA Eng Comm Duration: 1.45" A dime-shaped, biodegradeable plastic wafer inserted in the brain can deliver cancer-fighting chemotherapy, according to American researchers at the John Hopkins University. And the radical new procedure appears to avoid the usual side effects that make most chemotherapies difficult to tolerate. The wafer is implanted during the course of necessary surgery. Patients like Nicholas Tirone, who had a life-threatening brain tumour five years ago, turned to the method as a last hope. The drug is released in the body to home in on the tumour target during the two to three weeks in which the wafer degrades, said Dr Henry Brem, principal investigator for the Polymer Brain Tumour Treatment Group. In a study of 222 patients with recurrent glioma -- a brain tumour -- the median survival rate of 110 patients who received the anti-cancer agent was 31 weeks, compared with 23 weeks for others. All patients had end-stage disease and had failed conventional and experimental therapy. What was significant was that the improvement occurred without nauseating side effects. Three years after his surgery, Nicholas Tirone's prognosis is still guarded. But he leads a full life, working 50 hours a week and is very active. Researchers continue to work with newer polymers and drugs but the process used in Tirone's case is expected to be widely available in clinical trials within months. SHOWS: Nicholas Tirone in kitchen cutting and preparing food/ sot Nicholas on his illness/ Nicholas cooking/ researcher at lab at John Hopkins University/ Dr Henry Brem of Johns Hopkins SOT/ graphics of procedure/ vs discs/ vs surgery being performed/ Nicholas Tirone with family/ sot Nicholas on his active life and getting a second chance. You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/cb95d9ec69d485ed9658df6182ba1c31 Find out more about AP Archive: http://www.aparchive.com/HowWeWork
Views: 106 AP Archive
Prostate Cancer Surgery
Bladder Neck Transection and Prostatic Pedicle Ligation